TerrAscend Corp. (TSX:TSND)
Canada · Delayed Price · Currency is CAD | Market Cap | 250.43M -33.0% |
| Revenue (ttm) | 374.77M +1.1% |
| Net Income | -58.93M |
| EPS | -0.19 |
| Shares Out | 309.18M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 196,765 |
| Open | 0.8000 |
| Previous Close | 0.8100 |
| Day's Range | 0.7700 - 0.8100 |
| 52-Week Range | 0.5300 - 2.0000 |
| Beta | 2.02 |
| Analysts | Strong Buy |
| Price Target | 1.87 (+130.86%) |
| Earnings Date | Aug 6, 2026 |
About TerrAscend
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headqu... [Read more]
Full Company ProfileFinancial Performance
In 2025, TerrAscend's revenue was $260.56 million, a decrease of -2.81% compared to the previous year's $268.08 million. Losses were -$86.23 million, 7.47% more than in 2024.
Financial numbers in USD Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for TSND stock is "Strong Buy." The 12-month stock price target is $1.87, which is an increase of 130.86% from the latest price.
News
TerrAscend Earnings Call Transcript: Q2 2026
Revenue, gross margin, and adjusted EBITDA all grew sequentially and year-over-year, with strong performance in core Northeast markets and continued positive cash flow. Regulatory changes and disciplined M&A are expected to drive further growth and profitability.
TerrAscend Earnings release: Q2 2026
TerrAscend released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
TerrAscend Slides: Q2 2026
TerrAscend has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
TerrAscend Registration statement: Q2 2026
TerrAscend filed a registration statement on August 6, 2026, providing details about a securities offering with the SEC.
3 Top Marijuana Stocks For Investors To Know About Before The Next Run
Outside of the stock market, what do investors look for that gives them an idea of which top marijuana stocks to buy? Well, the answer comes down to different variables depending on the investor. If y...
TerrAscend to Host Second Quarter 2026 Earnings Conference Call
TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that it will host a scheduled confer...
TerrAscend Signs Agreement to Acquire Fifth Dispensary in New Jersey
Aunt Mary's, a high-performing dispensary in Hunterdon County, generates over $10 million in annualized revenue Transaction expected to be immediately accretive on an EBITDA and free cash flow basis, ...
TerrAscend Files Preliminary Proxy Statement for Special Meeting of Shareholders in Preparation for Uplisting to US Exchange
TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that it has filed a preliminary prox...
TerrAscend Completes Oversubscribed Debt Financing, Raising $21.7 Million
A portion of the proceeds were used to retire existing higher interest rate indebtedness with the remainder available for M&A A portion of the proceeds were used to retire existing higher interest rat...
TerrAscend Announces Results of Annual General Meeting
TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced the results of its a...
TerrAscend Transcript: AGM 2026
The meeting addressed director elections, auditor ratification, and approvals for stock option and RSU plans, all of which passed with shareholder approval. Voting was conducted online, and results will be announced via press release and Form 8-K.
TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting
Special meeting will allow shareholders to vote on share consolidation to support potential uplisting to a U.S. stock exchange Special meeting will allow shareholders to vote on share consolidation to...
TerrAscend Slides: Investor presentation
TerrAscend has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
TerrAscend Earnings Call Transcript: Q1 2026
Revenue reached $65.5M in Q1 2026 with strong gross and EBITDA margins, driven by operational efficiencies and growth in core Northeast markets. Regulatory changes, including medical cannabis rescheduling, are expected to further boost profitability and strategic flexibility.
TerrAscend Earnings release: Q1 2026
TerrAscend released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
TerrAscend Slides: Q1 2026
TerrAscend has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
TerrAscend Reports First Quarter 2026 Financial Results
Net Revenue of $65.5 million and Gross Profit Margin of 52.8% for Q1 2026 Q1 2026 Net Cash Provided from Continuing Operations of $8.7 million, representing 13.3% Operating Cash Flow Yield 1 Q1 2026 F...
TerrAscend Slides: Investor presentation
TerrAscend has posted slides in relation to its latest quarterly earnings report, which was published on April 28, 2026.
TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call
First Quarter 2026 Net Revenue Totaled $65.5 million with Gross Profit Margin of 52.8% First Quarter 2026 Net Revenue Totaled $65.5 million with Gross Profit Margin of 52.8%
TerrAscend Earnings Call Transcript: Q4 2025
Q4 and full year 2025 saw strong margins, positive cash flow, and stable Adjusted EBITDA despite revenue headwinds. Expanded in New Jersey and Ohio, exited Michigan, and maintained disciplined M&A and capital allocation. Gross margins exceeded 52% for the year.
TerrAscend Earnings release: Q4 2025
TerrAscend released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
TerrAscend Slides: Q4 2025
TerrAscend has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results
Net Revenue of $66.1 million for Q4 2025 and $260.6 Million for FY 2025 Gross Profit Margin of 52.1% for Q4 2025 and 52.3% for FY 2025 from continuing operations Q4 2025 Net Cash provided from contin...
TerrAscend closes Union Chill dispensary transaction
TerrAscend (TSNDF) announced that its consolidated entities closed on the previously announced transaction with Union Chill Cannabis Company, a high-performing dispensary in Hunterdon County. The tran...
TerrAscend Increases Retail Footprint in New Jersey with Closing of Union Chill Dispensary Transaction
Expands New Jersey retail footprint to four dispensaries Dispensary generates over $11 million in annualized revenue and is expected to be immediately accretive to EBITDA and cashflow Transaction fur...